- Report
- February 2024
- 200 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- February 2024
- 200 Pages
Global
From €3852EUR$4,000USD£3,313GBP
- Report
- January 2024
- 175 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- January 2024
- 175 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- January 2024
- 200 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- January 2024
- 200 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- January 2024
- 200 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- January 2024
- 200 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- January 2024
- 200 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- December 2023
- 200 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- May 2024
- 182 Pages
Global
From €3249EUR$3,374USD£2,794GBP
€3610EUR$3,749USD£3,105GBP
- Report
- March 2024
- 143 Pages
Global
From €3755EUR$3,899USD£3,229GBP
- Report
- January 2024
- 144 Pages
Global
From €3755EUR$3,899USD£3,229GBP
- Report
- November 2023
- 149 Pages
Global
From €2407EUR$2,499USD£2,070GBP
- Report
- October 2023
- 113 Pages
Global
From €5730EUR$5,950USD£4,928GBP
- Report
- March 2024
- 146 Pages
Global
From €2888EUR$2,999USD£2,484GBP
- Report
- February 2024
- 200 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- January 2024
- 200 Pages
Global
From €3852EUR$4,000USD£3,313GBP
- Report
- January 2024
- 190 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Report
- January 2024
- 193 Pages
Global
From €3499EUR$3,633USD£3,009GBP
€4998EUR$5,190USD£4,298GBP
The Antimicrobial Resistance (AMR) market is a subset of the healthcare services industry that focuses on the development of treatments and strategies to combat the growing threat of drug-resistant bacteria. AMR is a major public health concern, as it can lead to increased morbidity and mortality, as well as higher healthcare costs. To address this issue, the market is focused on developing new antibiotics, diagnostics, and vaccines, as well as strategies to reduce the spread of drug-resistant bacteria. Additionally, the market is focused on improving the stewardship of existing antibiotics, as well as developing new strategies to reduce the emergence of drug-resistant bacteria.
Some companies in the AMR market include Merck & Co., Pfizer, GlaxoSmithKline, Sanofi, Johnson & Johnson, Novartis, and AstraZeneca. Show Less Read more